T C Wright

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. ncbi request reprint Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial
    Lynette Denny
    Department of Obstetrics and Gynaecology, University of Cape Town, Cape Town, South Africa
    JAMA 294:2173-81. 2005
  2. ncbi request reprint Human papillomavirus (HPV) detection among human immunodeficiency virus-infected pregnant Thai women: implications for future HPV immunization
    Liesbeth J M Bollen
    Thailand MOPH US CDC Collaboration, Nonthaburi, Rajavithi Hospital, Bangkok, Thailand, and Columbia University, New York, New York, USA
    Sex Transm Dis 33:259-64. 2006
  3. doi request reprint Age considerations when vaccinating against HPV
    Thomas C Wright
    Columbia University, New York, New York 10032, USA
    Gynecol Oncol 109:S40-7. 2008
  4. doi request reprint Alternative approaches to cervical cancer screening for developing countries
    Thomas C Wright
    Department of Pathology, College of Physicians and Surgeons of Columbia University, Room 16 404, P and S Building, 630 W 168th Street, New York, NY 10032, USA
    Best Pract Res Clin Obstet Gynaecol 26:197-208. 2012
  5. pmc Reduced acquisition and reactivation of human papillomavirus infections among older women treated with cryotherapy: results from a randomized trial in South Africa
    Sylvia Taylor
    Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA
    BMC Med 8:40. 2010
  6. ncbi request reprint 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ
    Thomas C Wright
    Department of Pathology, College of Physicians and Surgeons of Columbia University, New York, NY, USA
    J Low Genit Tract Dis 11:223-39. 2007
  7. ncbi request reprint Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening
    Thomas C Wright
    Department of Pathology, College of Physicians and Surgeons of Columbia University, Room 16 404 P and S Building, 630 West 168th Street, New York, NY 10032, USA
    Obstet Gynecol 103:304-9. 2004
  8. ncbi request reprint 2006 consensus guidelines for the management of women with abnormal cervical screening tests
    Thomas C Wright
    Department of Pathology, College of Physicians and Surgeons of Columbia University, New York, NY, USA
    J Low Genit Tract Dis 11:201-22. 2007
  9. ncbi request reprint Chapter 14: HPV vaccine introduction in industrialized countries
    Thomas C Wright
    Department of Pathology, Columbia University, 630 W 168th Street, New York, NY 10032, USA
    Vaccine 24:S3/122-31. 2006
  10. ncbi request reprint Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts
    Thomas C Wright
    Department of Pathology, Columbia University, 630 W 168th Street, NY 10032, USA
    Vaccine 24:S3/251-61. 2006

Detail Information

Publications57

  1. ncbi request reprint Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial
    Lynette Denny
    Department of Obstetrics and Gynaecology, University of Cape Town, Cape Town, South Africa
    JAMA 294:2173-81. 2005
    ..Non-cytology-based screen-and-treat approaches for cervical cancer prevention have been developed for low-resource settings, but few have directly addressed efficacy...
  2. ncbi request reprint Human papillomavirus (HPV) detection among human immunodeficiency virus-infected pregnant Thai women: implications for future HPV immunization
    Liesbeth J M Bollen
    Thailand MOPH US CDC Collaboration, Nonthaburi, Rajavithi Hospital, Bangkok, Thailand, and Columbia University, New York, New York, USA
    Sex Transm Dis 33:259-64. 2006
    ..Prophylactic vaccines targeting HPV types 16 and 18 are being evaluated for efficacy among young women...
  3. doi request reprint Age considerations when vaccinating against HPV
    Thomas C Wright
    Columbia University, New York, New York 10032, USA
    Gynecol Oncol 109:S40-7. 2008
    ..This review discusses the various considerations that should be addressed when making recommendations of who should be vaccinated against HPV...
  4. doi request reprint Alternative approaches to cervical cancer screening for developing countries
    Thomas C Wright
    Department of Pathology, College of Physicians and Surgeons of Columbia University, Room 16 404, P and S Building, 630 W 168th Street, New York, NY 10032, USA
    Best Pract Res Clin Obstet Gynaecol 26:197-208. 2012
    ....
  5. pmc Reduced acquisition and reactivation of human papillomavirus infections among older women treated with cryotherapy: results from a randomized trial in South Africa
    Sylvia Taylor
    Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA
    BMC Med 8:40. 2010
    ..We investigated whether cervical cryotherapy reduces newly detected hrHPV infections among HIV-positive and HIV-negative women who were hrHPV negative when treated...
  6. ncbi request reprint 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ
    Thomas C Wright
    Department of Pathology, College of Physicians and Surgeons of Columbia University, New York, NY, USA
    J Low Genit Tract Dis 11:223-39. 2007
    ..To provide updated consensus guidelines for the management of women with cervical intraepithelial neoplasia (CIN) or adenocarcinoma in situ (AIS)...
  7. ncbi request reprint Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening
    Thomas C Wright
    Department of Pathology, College of Physicians and Surgeons of Columbia University, Room 16 404 P and S Building, 630 West 168th Street, New York, NY 10032, USA
    Obstet Gynecol 103:304-9. 2004
    ..If test results of either are abnormal, colposcopy should then be performed. This guidance should assist clinicians in utilizing HPV DNA testing in an effective manner, while minimizing unnecessary evaluations and treatments...
  8. ncbi request reprint 2006 consensus guidelines for the management of women with abnormal cervical screening tests
    Thomas C Wright
    Department of Pathology, College of Physicians and Surgeons of Columbia University, New York, NY, USA
    J Low Genit Tract Dis 11:201-22. 2007
    ..To provide revised evidence-based consensus guidelines for managing women with abnormal cervical cancer screening test results...
  9. ncbi request reprint Chapter 14: HPV vaccine introduction in industrialized countries
    Thomas C Wright
    Department of Pathology, Columbia University, 630 W 168th Street, New York, NY 10032, USA
    Vaccine 24:S3/122-31. 2006
    ..Human papillomavirus (HPV) vaccination provides unique challenges in all of these areas because of the many gaps in our knowledge...
  10. ncbi request reprint Chapter 30: HPV vaccines and screening in the prevention of cervical cancer; conclusions from a 2006 workshop of international experts
    Thomas C Wright
    Department of Pathology, Columbia University, 630 W 168th Street, NY 10032, USA
    Vaccine 24:S3/251-61. 2006
    ..In this summary, we summarize the opinions of this expert group on how these advances can be introduced to provide the maximum benefit to women and to reduce the global burden of cervical cancer...
  11. ncbi request reprint Cervical cancer screening in the 21st century: is it time to retire the PAP smear?
    Thomas C Wright
    Department of Pathology, Columbia University, New York, NY 10032, USA
    Clin Obstet Gynecol 50:313-23. 2007
    ..Therefore, in the future it is likely that we will use HPV testing alone to screen, and reserve cervical cytology as a way to determine which HPV-positive women require additional follow-up or colposcopy...
  12. ncbi request reprint 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ
    Thomas C Wright
    Department of Pathology, College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA
    Am J Obstet Gynecol 197:340-5. 2007
    ..Moreover, management recommendations for women with biopsy-confirmed adenocarcinoma in situ are now included...
  13. ncbi request reprint 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests
    Thomas C Wright
    Department of Pathology, College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA
    Am J Obstet Gynecol 197:346-55. 2007
    ..The 2004 Interim Guidance for HPV testing as an adjunct to cervical cytology for screening in women 30 years of age and older was formally adopted with only very minor modifications...
  14. ncbi request reprint Use of visual screening methods for cervical cancer screening
    Thomas C Wright
    Department of Pathology, Columbia University, 630 West 168th Street, New York, NY 10032, USA
    Obstet Gynecol Clin North Am 29:701-34. 2002
    ..In the near future we should be able to determine whether these approaches should be incorporated into routine clinical care...
  15. ncbi request reprint HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer
    T C Wright
    Department of Pathology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA
    JAMA 283:81-6. 2000
    ..In many other regions of the world, there is only limited access to cervical cancer screening...
  16. ncbi request reprint 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities
    Thomas C Wright
    Department of Pathology, College of Physicians and Surgeons of Columbia University, Room 16 404, P and S Bldg, 630 W 168th St, New York, NY 10032, USA
    JAMA 287:2120-9. 2002
    ..To provide evidence-based consensus guidelines for the management of women with cervical cytological abnormalities and cervical cancer precursors...
  17. ncbi request reprint Human immunodeficiency virus 1 expression in the female genital tract in association with cervical inflammation and ulceration
    T C Wright
    Department of Pathology, College of Physicians and Surgeons of Columbia University, New York, New York 10032, USA
    Am J Obstet Gynecol 184:279-85. 2001
    ....
  18. ncbi request reprint 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia
    Thomas C Wright
    Department of Pathology, College of Physicians and Surgeons of Columbia University, New York, USA
    Am J Obstet Gynecol 189:295-304. 2003
    ....
  19. ncbi request reprint Estradiol-induced hyperplasia in endometrial biopsies from women on hormone replacement therapy
    Thomas C Wright
    Department of Pathology, Columbia University Presbiterian Medical Center, New York, New York 10032, USA
    Am J Surg Pathol 26:1269-75. 2002
  20. ncbi request reprint Molecular variants of human papillomavirus type 16 and risk for cervical neoplasia in South Africa
    J J Tu
    Department of Pathology, Weill Medical College of Cornell University, New York, New York, USA
    Int J Gynecol Cancer 16:736-42. 2006
    ..In this setting where African HPV 16 variants were common, no increased risk for cervical neoplasia was found among women with these variants compared with other HPV 16 variants...
  21. ncbi request reprint Prevalence of visible disruption of cervical epithelium and cervical ectopy in African women using Depo-Provera
    L Kuhn
    Gertrude H Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA
    Contraception 59:363-7. 1999
    ....
  22. ncbi request reprint HPV DNA testing for cervical cancer screening. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer
    Thomas C Wright
    Department of Pathology, Columbia University, New York, USA tcw1columbia edu
    Int J Gynaecol Obstet 95:S239-46. 2006
  23. ncbi request reprint Anal intraepithelial neoplasia in heterosexual and homosexual HIV-positive men with access to antiretroviral therapy
    T J Wilkin
    Division of International Medicine and Infectious Diseases, Weill Medical College of Cornell University, New York, New York 10011, USA
    J Infect Dis 190:1685-91. 2004
    ....
  24. ncbi request reprint Is viral status needed before vaccination?
    Thomas C Wright
    Department of Pathology, Columbia University, Room 16 404, P and S Building, 630 West 168th Street, New York, NY, United States
    Vaccine 26:A12-5. 2008
    ..The increase in cost and the other barriers afforded by a prior to vaccination test requirement would result in a lower coverage, the key indicator of a successful vaccination program...
  25. ncbi request reprint Direct comparison of liquid-based and conventional cytology in a South African screening trial
    Sylvia Taylor
    Department of Pathology, Columbia University, New York, NY 10032, USA
    Int J Cancer 118:957-62. 2006
    ..Because of the higher unit cost of LBC, low resource settings should carefully consider the potential benefits and drawbacks of LBC before adopting this new technology...
  26. ncbi request reprint Adding a test for human papillomavirus DNA to cervical-cancer screening
    Thomas C Wright
    Department of Pathology, College of Physicians and Surgeons of Columbia University, New York, USA
    N Engl J Med 348:489-90. 2003
  27. doi request reprint Efficacy of human papillomavirus-based screen-and-treat for cervical cancer prevention among HIV-infected women
    Louise Kuhn
    Gertrude H Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA
    AIDS 24:2553-61. 2010
    ..Here, we evaluate the efficacy among HIV-infected women of a simpler, screen-and-treat strategy in which all women with a positive screening test are treated with cryotherapy...
  28. ncbi request reprint Prevalence of underlying adenocarcinoma in women with atypical endometrial hyperplasia
    Jamie Shutter
    Department of Pathology, Columbia University Medical Center, New York, New York 10032, USA
    Int J Gynecol Pathol 24:313-8. 2005
    ..025). In conclusion, there is a high prevalence of underlying endometrial adenocarcinoma among women undergoing hysterectomy for any of atypical endometrial proliferation...
  29. pmc Differential subtraction chain, a method for identifying differences in genomic DNA and mRNA
    J H Luo
    Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA 15261, USA
    Nucleic Acids Res 27:e24. 1999
    ..Overall, DSC represents a fast, efficient and sensitive method for identifying differences in genomic DNA and mRNA and can be easily applied in a variety of biological systems...
  30. ncbi request reprint Impact of utilizing p16INK4A immunohistochemistry on estimated performance of three cervical cancer screening tests
    Qi Zhang
    Department of Pathology, Columbia University, New York, NY, USA
    Int J Cancer 120:351-6. 2007
    ..In contrast, the sensitivity of other tests, such as VIA, may be overestimated with an imperfect gold standard...
  31. ncbi request reprint Effective cervical neoplasia detection with a novel optical detection system: a randomized trial
    Ronald D Alvarez
    University of Alabama at Birmingham, Birmingham, AL, USA
    Gynecol Oncol 104:281-9. 2007
    ..To assess whether the use of a novel optical detection system (ODS) as an adjunct to colposcopy increases the detection of biopsy-confirmed CIN 2,3...
  32. ncbi request reprint Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more
    Sue J Goldie
    Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts 02115 5924, USA
    Obstet Gynecol 103:619-31. 2004
    ..To evaluate the cost-effectiveness of human papillomavirus (HPV) DNA testing as a primary screening test in combination with cervical cytology in women aged 30 years or more...
  33. ncbi request reprint Direct visual inspection for cervical cancer screening: an analysis of factors influencing test performance
    Lynette Denny
    Department of Obstetrics and Gynecology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
    Cancer 94:1699-707. 2002
    ..The authors evaluated direct visual inspection of the cervix after the application of 5% acetic acid (DVI) as a cervical cancer screening test for use in low-resource settings...
  34. ncbi request reprint Cervical cancer prevention for all the world's women: new approaches offer opportunities and promise
    Thomas C Wright
    Diagn Cytopathol 35:845-8. 2007
  35. ncbi request reprint Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance
    Jane J Kim
    Department of Health Policy and Management, Harvard Center for Risk Analysis, 718 Huntington Ave, Second Floor, Boston, MA 02115, USA
    JAMA 287:2382-90. 2002
    ..Every year approximately 2 million US women are diagnosed as having a cervical cytological result of atypical squamous cells of undetermined significance (ASC-US)...
  36. ncbi request reprint HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study
    Lois J Conley
    Division of HIV AIDS Prevention, Surveillance, and Epidemiology, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Services, Atlanta, GA, USA
    Lancet 359:108-13. 2002
    ..Our aim was to investigate the incidence of these lesions in HIV-1-positive and HIV-1-negative women and to examine risk factors for disease...
  37. ncbi request reprint Visualization techniques (colposcopy, direct visual inspection, and spectroscopic and other visual methods). Summary of task force 7
    Thomas C Wright
    MediSpectra Inc, Lexington, Massachusetts, USA
    Acta Cytol 46:793-800. 2002
    ..The novel high-technology visual screening methods that utilize electrooptical sensors to identify cervical abnormalities are still in the developmental phases but offer considerable potential...
  38. ncbi request reprint A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine
    Sue J Goldie
    Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115, USA
    Int J Cancer 106:896-904. 2003
    ..These include a better understanding of the heterogeneity of vaccine response, the effect of type-specific vaccination on other HPV types and the degree to which vaccination effect persists over time...
  39. ncbi request reprint Cervical cancer control, priorities and new directions
    Joseph Monsonego
    EUROGIN, Paris, France
    Int J Cancer 108:329-33. 2004
    ..We report the conclusions of the Experts' Meeting at the EUROGIN 2003 conference...
  40. ncbi request reprint Dynamics of human papillomavirus infection between biopsy and excision of cervical intraepithelial neoplasia: results from the ZYC101a protocol
    Christopher P Crum
    Department of Pathology, Brigham and Women s Hospital, Boston, Massachusettsm USA
    J Infect Dis 189:1348-54. 2004
    ..Little is known about the dynamics of human papillomavirus (HPV) during the follow-up of cervical intraepithelial neoplasia (CIN) 2/3 after biopsy...
  41. ncbi request reprint Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine
    Sue J Goldie
    Department of Health Policy and Management, Harvard School of Public Health, Boston, MA 02115 5924, USA
    J Natl Cancer Inst 96:604-15. 2004
    ..We explored the clinical benefits and cost-effectiveness of introducing an HPV16/18 vaccine in a population with an organized cervical cancer screening program...
  42. ncbi request reprint Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, The Netherlands, France, and Italy
    Jane J Kim
    Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA
    J Natl Cancer Inst 97:888-95. 2005
    ..We assessed the cost-effectiveness of incorporating HPV DNA testing into existing cervical cancer screening programs in the United Kingdom, The Netherlands, France, and Italy...
  43. ncbi request reprint Managing abnormal cytology results in pregnancy
    Stewart L Massad
    Department of Obstetrics and Gynecology, Southern Illinois University School of Medicine, PO Box 19640, Springfield, IL 62794, USA
    J Low Genit Tract Dis 9:146-8. 2005
  44. ncbi request reprint Can cervicography be improved? An evaluation with arbitrated cervicography interpretations
    Diana L Schneider
    Division of Immigration Health Services, US Public Health Service, Washington, DC 20536, USA
    Am J Obstet Gynecol 187:15-23. 2002
    ..The purpose of this study was to estimate the optimal performance of cervicography. We compared an arbitrated cervigram classification with an arbitrated referent diagnosis of cervical neoplasia...
  45. ncbi request reprint Acceptability of self-collection of specimens for HPV DNA testing in an urban population
    R Anhang
    Harvard University, Boston, Massachusetts, USA
    J Womens Health (Larchmt) 14:721-8. 2005
    ....
  46. ncbi request reprint The 2001 Bethesda System terminology
    Barbara S Apgar
    Department of Family Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA
    Am Fam Physician 68:1992-8. 2003
    ..The presence of normal or abnormal endometrial cells is to be reported in women who are at least 40 years of age. Educational notes and comments on ancillary testing may be added as appropriate...
  47. ncbi request reprint Cost-effectiveness of cervical-cancer screening in five developing countries
    Sue J Goldie
    Department of Health Policy and Management, Harvard School of Public Health, Boston, USA
    N Engl J Med 353:2158-68. 2005
    ..Cervical-cancer screening strategies that involve the use of conventional cytology and require multiple visits have been impractical in developing countries...
  48. ncbi request reprint Cervical cancer prevention - a paradigm shift?
    Lynnette Denny
    University of Cape Town, Groote Schuur Hospital, H 45, Old Main Building, Observatory 7925, South Africa
    Gynecol Oncol 99:S12. 2005
  49. ncbi request reprint Concomitant Essure tubal sterilization and Thermachoice endometrial ablation: feasibility and safety
    Rafael F Valle
    Northwestern University Medical School, Chicago, Illinois 60611, USA
    Fertil Steril 86:152-8. 2006
    ..Somerville, NJ) and transcervical sterilization by intratubal insert (Essure Permanent Birth Control System; Conceptus, San Carlos, CA)...
  50. ncbi request reprint News media coverage of human papillomavirus
    Rebecca Anhang
    Harvard Center for Risk Analysis, Harvard School of Public Health, 718 Huntington Avenue, Suite 2, Boston, MA 02115 5924, USA
    Cancer 100:308-14. 2004
    ....
  51. ncbi request reprint Women's desired information about human papillomavirus
    Rebecca Anhang
    Harvard Center for Risk Analysis, Harvard School of Public Health, 718 Huntington Avenue, Suite 2, Boston, MA 02115 5924, USA
    Cancer 100:315-20. 2004
    ..However, little is known about women's questions and concerns about HPV or their attitudes toward HPV testing...
  52. ncbi request reprint Chapter 29: Knowledge gaps and priorities for research on prevention of HPV infection and cervical cancer
    Eduardo L Franco
    Division of Cancer Epidemiology, Departments of Oncology and Epidemiology and Biostatistics, McGill University, 546 Pine Avenue West, Montreal, Quebec, Canada
    Vaccine 24:S3/242-9. 2006
    ..The field of HPV and cervical cancer prevention has never been so multi-disciplinary. A new era has begun and the challenges are many...
  53. ncbi request reprint The carcinogenicity of human papillomavirus types reflects viral evolution
    Mark Schiffman
    Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Bethesda, MA, USA
    Virology 337:76-84. 2005
    ..These results present several clear clues and research directions in our ongoing efforts to understand HPV carcinogenesis...
  54. ncbi request reprint The menstrual cycle does not affect human immunodeficiency virus type 1 levels in vaginal secretions
    Julie M Villanueva
    Department of Medicine, Emory University School of Medicine, Grady Infectious Disease Program, Atlanta, GA 30333, USA
    J Infect Dis 185:170-7. 2002
    ..VVLs were not correlated with plasma estradiol or progesterone levels (P>.05). These results suggest that hormonal changes during the menstrual cycle do not have a significant effect on HIV-1 RNA levels in vaginal secretions...
  55. ncbi request reprint Increased detection of high-grade cervical intraepithelial neoplasia utilizing an optical detection system as an adjunct to colposcopy
    Ronald D Alvarez
    University of Alabama at Birmingham, Birmingham, Alabama, USA
    Gynecol Oncol 106:23-8. 2007
    ..To evaluate the impact of using a novel optical detection system (ODS) as an adjunct to colposcopy...
  56. pmc Alliance for cervical cancer prevention: setting the record straight
    Jacqueline Sherris
    Am J Public Health 97:200-1; author reply 201-202. 2007
  57. ncbi request reprint Nested case-control study of cervical mucosal lesions, ectopy, and incident HIV infection among women in Cape Town, South Africa
    Landon Myer
    Infectious Diseases Epidemiology Unit, School of Public Health and Family Medicine, University of Cape Town, South Africa
    Sex Transm Dis 33:683-7. 2006
    ..The objective of this study was to test whether cervical mucosal lesions and ectopy increase women's susceptibility to HIV infection...